Is estrogens, conjugated covered by Medicare Part D?
2,508 of 5,052 Medicare Part D plan offerings (49.6%) list estrogens, conjugated on their 2026 formulary, most often on tier 2; 4.3% of the formularies that cover it require prior authorization.
- Plans that cover it
- 49.6%
- 2,508 of 5,052 offerings; the median drug: 76%
- Usual tier
- Tier 2
- from tier 1 to tier 4
- Prior authorization
- 4.3%
- of formularies that cover it; the median drug: 1%
- Quantity limits
- 0%
- of formularies that cover it; the median drug: 30%
Source: CMS Part D formulary file, 2026 second quarter: the formularies in use in 2026. A plan's 2027 formulary can differ; check your own plan's coverage in Medicare Plan Finder.
What does it cost under Part D in 2027?
- Your yearly cap in 2027
- Out-of-pocket spending on covered Part D drugs stops at $2,400 in 2027 ($2,100 in 2026); after that, you pay nothing for covered drugs for the rest of the year.
- The deductible
- A plan's drug deductible is at most $700 in 2027 ($615 in 2026); many plans charge less or none.
Source: CMS, Announcement of calendar year 2027 Part D parameters; Medicare.gov, “How much does Medicare drug coverage cost?” (read Oct. 7, 2026).
Which forms and strengths are counted?
- estrogens, conjugated (USP) 0.3 mg oral tablet
- estrogens, conjugated (USP) 0.45 mg oral tablet
- estrogens, conjugated (USP) 0.625 mg oral tablet
- estrogens, conjugated (USP) 0.9 mg oral tablet
- estrogens, conjugated (USP) 1.25 mg oral tablet
Which other versions are listed?
The same ingredients under other names, each with its own coverage and spending.
- Premarin (estrogens, conjugated)90% of plan offerings
What else should you check?
- Stand-alone drug plans for 2027Premiums and deductibles
- Drugs Medicare spends the most onThe 2024 spending list
- 2027 costs and limitsDeductibles and out-of-pocket limits
Data, not medical advice. Coverage is the share of plan formularies listing the drug; your plan's formulary, tier and pharmacy decide what you pay.